SEC 13F Intelligence

Hourglass Capital, LLC / PFE

Hourglass Capital, LLC’s Pfizer Inc Position

Does Hourglass Capital, LLC own Pfizer Inc (PFE)? Yes347.6K shares worth $10M (+2.03% of its 13F portfolio) as of Q1 2026, down from 438.1K shares the prior filed quarter.

Position Value
$10M
Q1 2026
Shares
347.6K
% of Portfolio
+2.03%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $7MQ2 ’19: $7MQ3 ’19: $6MQ4 ’19: $7MQ4 ’19Q1 ’20: $6MQ2 ’20: $6MQ3 ’20: $7MQ4 ’20: $6MQ4 ’20Q1 ’21: $6MQ2 ’21: $6MQ3 ’21: $6MQ4 ’21: $7MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ3 ’22: $3MQ4 ’22: $3MQ4 ’22Q1 ’23: $3MQ2 ’23: $4MQ3 ’23: $3MQ4 ’23: $8MQ4 ’23Q1 ’24: $8MQ2 ’24: $8MQ3 ’24: $8MQ4 ’24: $11MQ4 ’24Q1 ’25: $10MQ2 ’25: $11MQ3 ’25: $12MQ4 ’25: $11MQ4 ’25Q1 ’26: $10Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026347.6K$10M+2.03%
Q4 2025438.1K$11M+2.35%
Q3 2025470.5K$12M+2.69%
Q2 2025436.4K$11M+2.62%
Q1 2025400.5K$10M+2.66%
Q4 2024397.7K$11M+2.91%
Q3 2024279.9K$8M+2.26%
Q2 2024287.3K$8M+2.39%
Q1 2024281.6K$8M+2.35%
Q4 2023275.6K$8M+2.56%
Q3 2023105.0K$3M+1.23%
Q2 202399.6K$4M+1.27%
Q1 202363.4K$3M+0.93%
Q4 202263.5K$3M+1.15%
Q3 202263.4K$3M+1.05%
Q2 202263.0K$3M+1.17%
Q1 202263.0K$3M+1.02%
Q4 2021116.0K$7M+2.29%
Q3 2021143.2K$6M+1.68%
Q2 2021163.0K$6M+1.49%
Q1 2021159.4K$6M+1.46%
Q4 2020161.7K$6M+1.77%
Q3 2020179.9K$7M+2.23%
Q2 2020176.2K$6M+2.04%
Q1 2020176.2K$6M+2.44%
Q4 2019179.7K$7M+1.91%
Q3 2019157.7K$6M+1.61%
Q2 2019168.0K$7M+2.06%
Q1 2019161.7K$7M+2.00%
Q4 2018162.8K$7M+2.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hourglass Capital, LLC’s full portfolio or all institutional holders of PFE.